Results for tag: "Fungal Keratitis Drug"

Fungal Keratitis is an infection of the cornea caused by a fungus. It is a common cause of vision loss and can be treated with antifungal drugs. The Fungal Keratitis Drug market is a subset of the Optical Disorders Drugs market, which includes drugs used to treat a variety of eye diseases. Fungal Keratitis Drugs are used to treat the infection and reduce the risk of vision loss. These drugs are typically administered topically, either as eye drops or ointments. The Fungal Keratitis Drug market is highly competitive, with a number of companies offering products. Some of the major players in the market include Allergan, Bausch + Lomb, Santen Pharmaceuticals, and Sun Pharmaceuticals. Other companies in the market include Merck, Pfizer, and Novartis. Show Less Read more